Trying to stop the development of kidney cancer in Birt-Hogg-Dubé syndrome
Cancer types:
Kidney cancer
Project period:
–
Research institute:
Fondazione Telethon
Award amount:
£199,276
Location:
Italy
Dr Chiara Di Malta and her team are trying to gain a better understanding of why patients with a rare inherited disease are more likely to develop kidney cancer. They hope that their research will identify new treatment approaches for kidney cancer.
Hope for the future
Birt-Hogg-Dubé syndrome is a rare inherited disease that can predispose people to kidney cancer. Between 14-34% of people with the syndrome go on to develop tumours in their kidney and to date surgery is the only treatment option. Dr Chiara Di Malta and her team are now trying to find a new way to treat kidney cancer by studying certain proteins that have also been found aberrantly activated in other cancers.
Meet the scientist
Dr Chiara Di Malta loves playing with her two children, preparing home-made cookies and biking along the beautiful seafront of Naples. “My husband, Carmine, who is a scientist, but also a great chef, cooks many traditional dishes for us and my favourite is Neapolitan fish soup”. When not busy cooking with her family or going to jazz concerts or the opera with her husband, Dr Di Malta enjoys taking pictures of people and places and reading.
The science
People with Birt-Hogg-Dubé syndrome are about 7 times more likely than the average person to develop kidney cancer. Research suggests that TFEB, a protein that has already been implicated in other cancers, could be responsible for the development of cancer in people with Birt-Hogg-Dubé syndrome.
Dr Di Malta and her team are now investigating this idea by disabling the TFEB protein in Birt-Hogg-Dubé syndrome to see whether this stops kidney cancer from developing. They are also trying to understand how TFEB promotes tumour growth in Birt-Hogg-Dubé syndrome patients and how they can stop this process by inhibiting TFEB.
Without basic science, no technological breakthroughs would be possible. Only a better understanding of the mechanisms underlying a specific disease can allow to identify a better therapeutic strategy to treat it.
Active Finland
Kidney cancer
By studying the mechanisms that drive the growth of kidney cancer researchers are hoping to discover vital new ways to prevent it progressing and spreading.
Researcher: Dr Sakari Vanharanta
Improving our understanding of how to treat kidney cancer
Complete United Kingdom
Kidney cancer
Researchers hope to improve a current treatment by finding new combination drugs that could work alongside it and help it work for as many patients as possible.
Researcher: Professor Hardev Pandha
Three-pronged attack on kidney cancer
Active Spain
Lung cancer
This project hopes to find a way for immunotherapies to work better, for more cancer patients. Using cutting-edge technologies they will test out a potential new way to treat cancer and explore how to advance it towards the clinic.
Researcher: Dr Alfonso Calvo
Can we stop cancers hiding from immunotherapy?